The Korean Journal of Blood Transfusion : eISSN 2383-6881 / pISSN 1226-9336
Table. 1.

Summary of cases of Jr(+) red blood cell transfusions in patients with anti-Jra

Reference Year Age/sex Diagnosis Results Transfused volume Consequence
Titer Monocyte monolayer assay
28 1976 40/F Gynecologic surgery 64 - 2 mL* The half-life of transfused red blood cells: 80 minutes (no transfused red blood cells were detected 24 hours post-transfusion)
36 1995 35/F Cervical insufficiency 8 - 1 unit No hemolytic transfusion reaction
41 1986 28/F Labor complication 32 - 1,500 mL No transfused red blood cells were detected 35 days of post-transfusion
42 2004 69/M Gastrointestinal bleeding 32 3.3% 4 units No hemolytic transfusion reaction
45/F Aneurysm 32 24.5% 3 units Acute hemolytic transfusion reaction
43 1988 0/? Hemolytic disease of the newborn 32 - 488 mL No hemolytic transfusion reaction
72/F Esophageal cancer 16 - 1,400 mL No hemolytic transfusion reaction
44 2020 ?/F ? - - 16 units Acute hemolytic transfusion reaction
?/F ? - - 4 units Acute hemolytic transfusion reaction
?/? ? - - No hemolytic transfusion reaction
45 2005 31/F Postpartum bleeding 4 68.5% 15 units Delayed hemolytic transfusion reaction (mild)
46 2018 54/F Traffic accident - - 10 units Delayed hemolytic transfusion reaction
47 2007 57/F Aortic valve regurgitation - - 10 units Delayed hemolytic transfusion reaction (mild)

*Cr51-labeled red blood cells.

Whole blood.

Exchange transfusion using synthetic blood (hematocrit 40%).

Korean J Blood Transfus 2024;35:167-77 https://doi.org/10.17945/kjbt.2024.35.3.167
© 2024 Korean J Blood Transfus